Literature DB >> 1728790

Brain metastases from transitional cell carcinoma of urinary bladder.

R S Anderson1, A M el-Mahdi, D A Kuban, E M Higgins.   

Abstract

Of 293 patients with transitional cell carcinoma of the bladder seen at our institution between April 1977 and December 1987, 9 patients were found to have brain metastasis. Seven of 9 patients were found to have a solitary brain lesion, and in 4 of these, no other site of metastatic disease was identified. Five patients received palliative whole brain irradiation, 3,000 cGy in 10 fractions, due to the presence of multiple lesions of the central nervous system (CNS) or metastases to other sites. The average survival for this group was seven weeks. One patient with a solitary brain metastasis and no other documented metastatic site was hospitalized at another institution, and was managed expectantly receiving only parenteral steroid therapy and survived four weeks. Three patients with solitary lesions and no evidence of other metastatic sites were treated with a combined surgical and radiotherapeutic approach receiving 4,000-5,000 cGy to the lesion site postoperatively. The average survival of that group was twenty-nine months, with one five-year survivor and 1 patient with no evidence of disease fourteen months after treatment. It appears that survival is longer in those patients with solitary lesions, perhaps due, at least in part, to a more aggressive therapeutic approach.

Entities:  

Mesh:

Year:  1992        PMID: 1728790     DOI: 10.1016/0090-4295(92)90034-t

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  17 in total

1.  Multiple Skeletal Muscle Metastases in a Case of Transitional Cell Carcinoma of Bladder Detected by F-18 FDG PET/CT.

Authors:  Raghava Kashyap; Bhagwant Rai Mittal; Dhritiman Chakraborty; Anish Bhattacharya; Baljinder Singh
Journal:  Nucl Med Mol Imaging       Date:  2010-09-17

2.  Opportunistic Disease or Metastatic Lesions: A Rare Finding in a Patient with Bladder Cancer.

Authors:  Michael Simon; Natalie Elkayam; Jonathan Smerling; Michael Marcelin; Stephan Kamholz
Journal:  Curr Urol       Date:  2019-09-10

3.  Solitary cystic cerebellar metastasis in a patient with invasive transitional cell carcinoma of the bladder.

Authors:  Brianna Vaa; Manish Kohli; Katharine A Price; Keith Mark Swetz
Journal:  BMJ Case Rep       Date:  2014-06-11

Review 4.  Choroid plexus metastasis from carcinoma of the bladder: case report and review of the literature.

Authors:  R Qasho; V Tommaso; G Rocchi; U Simi; R Delfini
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

Review 5.  Gemcitabine and radiotherapy in the treatment of brain metastases from transitional cell carcinoma of the bladder: a case report.

Authors:  Chris Protzel; Uwe Zimmermann; Elke Asse; Gerhard Kallwellis; Klaus Juergen Klebingat
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

6.  Solitary brain metastases from carcinoma of the bladder.

Authors:  M Salvati; L Cervoni; E R Orlando; R Delfini
Journal:  J Neurooncol       Date:  1993-06       Impact factor: 4.130

7.  Cerebral metastasis during remission after immunotherapy for metastatic urothelial carcinoma: A case report.

Authors:  Shohei Iwata; Fusako Niimi; Tetsuya Danno; Sachi Honda; Takeshi Azuma
Journal:  Mol Clin Oncol       Date:  2021-05-24

8.  Central Nervous System Metastasis in Patients With Urothelial Carcinoma: Institutional Experience and a Comprehensive Review of the Literature.

Authors:  Leonidas N Diamantopoulos; Ali R Khaki; Guru P Sonpavde; Vyshak A Venur; Evan Y Yu; Jonathan L Wright; Petros Grivas
Journal:  Clin Genitourin Cancer       Date:  2019-12-05       Impact factor: 2.872

Review 9.  Management of metastatic brain tumors.

Authors:  R Sawaya; B L Ligon; R K Bindal
Journal:  Ann Surg Oncol       Date:  1994-03       Impact factor: 5.344

Review 10.  Transitional cell carcinoma presenting as a solitary brain lesion: a case report and review of the world literature.

Authors:  R E Clatterbuck; P Sampath; A Olivi
Journal:  J Neurooncol       Date:  1998-08       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.